Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,601–1,700 of 2,099
Glucose Uptake Is Increased by Estradiol Dipropionate in L6 Skeletal Muscle Cells
Yao, Y., Yang, X., Shen, J., & Zhao, P. (2022) · Pharmaceuticals · doi:10.3390/ph16010025 · Cited by 2
“As the primary site of insulin stimulated uptake of glucose, skeletal muscle is also considered to be a major driver of systemic insulin resistance [25,26].”
BackgroundAssociation of handgrip strength with new-onset CKD in Korean adults according to gender
Lee, S., Kim, M., Lee, H.-J., & Kim, J.-K. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2023.1148386 · Cited by 2
“Sarcopenia can lead to the inevitable deterioration of skeletal muscle cell structure and biological function (39) and can impair insulin-stimulated glucose disposal into muscle thereby impacting glucose homeostasis (38).”
BackgroundJennings, T., Janquart, M., Washak, C., Duddleston, K. N., & Kurtz, C. C. (2023) · Immunometabolism · doi:10.1097/in9.0000000000000029 · Cited by 7
“Skeletal muscle is responsible for 80% of glucose absorption under normal conditions; thus, resistance to insulin signaling in this tissue can greatly affect the function of skeletal muscle and promote IR and T2DM systemically [47,58].”
BackgroundExosomal RNA in type 2 diabetes mellitus and other metabolic diseases
Ghoshal, K. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-14008-2.00009-7 · Cited by 3
Subramanian, S. P. (2018) · Journal of Diabetes and Obesity · doi:10.15436/2376-0494.18.1690 · Cited by 2
Fink, K., Prebil, M., Vardjan, N., Jensen, J., Zorec, R., & Kreft, M. (2020) · Image Analysis & Stereology · doi:10.5566/ias.2356 · Cited by 3
“Insulin resistance in type 2 diabetes is an outcome of several deficiencies in signal transduction, which is proposed to start with a discrepancy in insulin action on receptor tissue, such as skeletal muscle, and then loss of function in β-cells because of hyperinsulinemia (DeFronzo and Tripathy, 2009).”
BackgroundOliver, M. H., Bloomfield, F. H., Bansal, A., Phua, H. H., Thorstensen, E. B., Harding, J. E., & Jaquiery, A. L. (2020) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174420001063 · Cited by 2
Too Much Sitting: A Serious 21st Century Health Risk
Eanes, L. S. (2021) · Orthopaedic Nursing · doi:10.1097/nor.0000000000000770 · Cited by 2
Davis, S. V. (2013) · Digital Commons - University of South Florida (University of South Florida) · Cited by 3
Tissue-specific insulin resistance in human obesity: A physiological approach to lipid metabolism
van der Kolk (2018) · Research Publications (Maastricht University) · doi:10.26481/dis.20180503bk · Cited by 2
Antidiabetic activity of aquilaria malaccensis (agarwood) leaves extracts
Liyana, Z. N. (2018) · UMP Institutional Repository (Universiti Malaysia Pahang) · Cited by 8
Balkrishna, A., Joshi, A. B., Das, S. K., Bisht, L., Sakat, S. S., Sharma, V., Sharma, N., Joshi, K., Verma, S., Sharma, V. K., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.02.15.950865 · Cited by 3
Matcha Tea and its Acute Effects on Postprandial Blood Glucose
Romash, R. G. (2018) · Arizona State University Library Digital Repository (Arizona State University) · Cited by 2
Effects of Chronic Electronic Cigarette Use on Glucose Metabolism
Hoskinson, H. (2017) · The Research Repository @ WVU (West Virginia University) · doi:10.33915/etd.5823 · Cited by 2
“The two major hallmarks of these pathologies are an aberrant insulin production by the pancreas and an altered action of insulin in peripheral tissues (29, 31).”
BackgroundInfluentialLi, P., Ji, B., Lappa, D., Meijnikman, A. S., Olsson, L. M., Aydin, Ö., Bruin, S. C., van de Laar, A. W. J. M., Tremaroli, V., Luo, H., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.26.489057 · Cited by 3
Admission glucose as a prognostic marker for all-cause mortality and cardiovascular diseasePreprint
Djupsjö, C., Kuhl, J., Andersson, T., Lundbäck, M., Holzmann, M. J., & Nyström, T. (2022) · Research Square · doi:10.21203/rs.3.rs-1715964/v1 · Cited by 2
Lee, K.-D., Sun, H.-J., Lee, M., Chun, J., Shin, T.-S., Choi, K. S., & Shim, S.-Y. (2022) · Microbiology and Biotechnology Letters · doi:10.48022/mbl.2109.09009 · Cited by 1
Bhalerao, S. S., Kharche, J. S., & Harke, S. (2022) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2022.11.002 · Cited by 1
Logesh, R., Hari, B., Chidambaram, K., & Das, N. (2024) · Gene · doi:10.1016/j.gene.2024.148216 · Cited by 1
Assessment of body compositions in the prediction of metabolic syndrome in adults
Hou, B., Li, Y., Liu, C., Zhang, Y., Wen, D., & Li, X. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-1724 · Cited by 4
Wang, X., Guo, Q., Huang, K., Ma, G., Zhai, L., Lin, B., Ren, H., & Yang, Z. X. (2024) · Medicine · doi:10.1097/md.0000000000039257 · Cited by 1
“[37,38] Moreover, a meta-analysis showed that low muscle quality and function were associated with COVID-19 disease severity.”
BackgroundMicrobiome-Targeted Therapies: Enhancing Resilience in Metabolic Disorders
Janiad, S., & Rehman, K. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_13 · Cited by 2
Circadian rhythms in muscle health and diseases
Kelu, J. J. (2024) · International review of cytology · doi:10.1016/bs.ircmb.2024.10.002 · Cited by 2
Kwak, S. E., Wang, H., Pan, X., Duan, D., & Cartee, G. D. (2024) · The FASEB Journal · doi:10.1096/fj.202401859r · Cited by 1
Song, C., Li, Q., Xia, C., Lu, L. O. N. G., Zeng, X., Li, J., & Chen, M. (2024) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2024.11.003 · Cited by 1
Agrawal, O. D., & Kulkarni, Y. A. (2025) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2024.101025 · Cited by 3
“This leads to increased oxidation of free fatty acids and decreased absorption of insulin-stimulated glucose in many organs, including the liver and skeletal muscle [28 – 30].”
Miura, K., Hasumura, M., Kitahara, Y., Nishitani, S., & Yamada, Y. (2025) · Functional Foods in Health and Disease · doi:10.31989/ffhd.v15i4.1582 · Cited by 6
Chaslin, M., Maroun, G., Durand, E., Bonafos, B., Assou, S., Chaiyut, J., Vaysse, L., Ferrer, V., Liengprayoon, S., Brioche, T., et al. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118072 · Cited by 3
Prepregnancy Obesity Reprograms Offspring Skeletal Muscle Fibre Transition Through H3K9me3
Wu, Y., Li, S., Zhang, J., Tian, A., Wang, X., Yang, X., Meng, F., Li, Q., Gao, Y., Li, Y., et al. (2025) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13825 · Cited by 1
“As the most abundant tissue in the human body, accounting for approximately 30%–40% of body mass, it serves as the primary site for insulin-mediated glucose uptake [13, 14].”
Tammineni, E. R., Figueroa, L., Fill, M., Riazi, S., & Manno, C. D. (2025) · Endocrinology Diabetes & Metabolism · doi:10.1002/edm2.70052 · Cited by 1
George, J., King, D. G., Shojaee‐Moradie, F., Whyte, M., Scott, M. J., & Rockall, T. (2025) · Clinical Nutrition ESPEN · doi:10.1016/j.clnesp.2025.05.021 · Cited by 1
Tang, Q., Li, W., Xu, X., Zhao, R., Zhao, Y., & Yao, Z. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1604230 · Cited by 1
“This interrelationship is also highlighted in the adipose tissue expandability hypothesis, which posits that individuals with higher SAT expansion capacity can buffer ectopic fat deposition and its metabolic complications (22).”
Patel, K., Eastwood, S. V., Wells, J. C. K., Chaturvedi, N., & Staatz, C. B. (2025) · Diabetologia · doi:10.1007/s00125-025-06473-9 · Cited by 1
“Skeletal muscle, proxied here by FFM, is an important determinant of type 2 diabetes risk [26].”
Anyiam, O., & IDRIS, I. R. (2025) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2025.2527791 · Cited by 1
“It is widely recognized that free The underlying pathogenesis of peripheral IR is not completely understood, excess IMCL, reduced insulin receptor activity and impaired intracellular insulin signaling pathways have been implicated [33,106].”
Beck, E. A., Hetrick, B., Nassar, L. R., Turnbull, D. W., Dean, T. A., Takahashi, D. L., GANNON, M. A., Wesolowski, S. R., Aagaard, K. M., Friedman, J. E., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-00828-3 · Cited by 1
“Dysregulation of skeletal muscle insulin-signaling and metabolism is a hallmark of insulin resistance and an underlying cause of cardiometabolic diseases and the progression of age-associated dysfunction 12 .”
Onishi, Y., Ichihashi, R., & Kasuga, M. (2025) · Internal Medicine · doi:10.2169/internalmedicine.5712-25 · Cited by 3
Wang, W., Liew, W. L., Huang, S., Chan, E., Tan, A. L. M., Tian, C., Tong, Y., Zhang, Y., Liu, F., Qin, Y., et al. (2025) · Cell Genomics · doi:10.1016/j.xgen.2025.100951 · Cited by 5
Seko, T., Himuro, N., Koyama, M., Nakata, K., Akasaka, H., Mori, M., Ogawa, S., Miura, S., & Ohnishi, H. (2025) · Diabetology International · doi:10.1007/s13340-025-00843-9 · Cited by 3
Kapralou, A. N., Yapijakis, C., & Chrousos, G. P. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47080657 · Cited by 1
Li, K., Liu, Y., Zhao, J., & Ye, Z. (2025) · Kidney Medicine · doi:10.1016/j.xkme.2025.101087 · Cited by 1
Suntharalingam, A. A., Sharma, A., Qvigstad, E., Sattar, N. A., Gill, J. M. R., Bjørnvall, C. D., Kalleklev, T., Shakya, P., van Hall, G., Norheim, F., et al. (2025) · Diabetologia · doi:10.1007/s00125-025-06546-9 · Cited by 2
“…aligns with prior studies indicating that lean first-degree relatives of individuals with type 2 diabetes often show muscle insulin resistance decades before diabetes onset [24], making it an early marker of systemic insulin resistance and a precursor to hyperglycaemia and type 2 diabetes [17].”
Wilson, E. P., Broadaway, K. A., Parsons, V. A., Vadlamudi, S., Narisu, N., Brotman, S. M., Currin, K. W., Stringham, H. M., Erdos, M. R., Welch, R., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.09.003 · Cited by 5
“11,12 24 Disruption of these processes in muscle tissue contributes to dyslipidemia, obesity, diabetes, and cardio-vascular disease.”
Early-life thymectomy results in visceral adipose tissue inflammation and glucose intolerance
Buckley, D. J., Zahedi, S., Velusamy, P., Sharma, S., Sabnani, M. K., Flores, L. C., Tandukar, G., Ikeno, Y., Fadel, P. J., Lesniewski, L. A., et al. (2025) · Immunity & Ageing · doi:10.1186/s12979-025-00531-x · Cited by 1
“…thymectomized mice: 1) That liver and/ or the pgWAT, but not the skeletal muscle was insulin resistant, but the ITT was not sensitive enough to detect these differences in insulin sensitivity ( i.e. only 10–20% insulin-stimulated glucose uptake in liver and adipose, 80% in skeletal muscle [50]).”
Ali, M. S., Bitsch‐Olsen, S., Frank, E., Battey, E., Perla, M., Themsen, S. S. B., Raun, S. H., de Jong, S., & Sylow, L. (2025) · The Journal of Physiology · doi:10.1113/jp288099 · Cited by 2
“Altogether, our results suggest that breast cancer-associated metabolic dysfunctions could, in part, be induced by abrogated skeletal muscle insulin signalling, likely via Rac1 signalling (DeFronzo & Tripathy, 2009; Roden & Shulman, 2019).”
Inulevs-A, a new sesquiterpene lactone from the leaves of Inula racemosa Hook. f."
Komal, K., Tappa, C., Sharma, K., et al. (2025) · Natural Product Research · doi:10.1080/14786419.2025.2569805 · Cited by 1
Huang, W., Wu, J., Shen, Z., Wang, D., & Wang, X. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1686885 · Cited by 4
Kumar, P., Gulzar, F., Chhikara, N., Maurya, A. K., Singh, S., Ahmad, I., Kanojiya, S., & Tamrakar, A. K. (2025) · The FASEB Journal · doi:10.1096/fj.202502570r · Cited by 1
“Skeletal muscle is the principal site for postprandial glucose utilization and the major determining factor of insulin sensitivity [65, 66].”
Zhou, H., Wang, Y., Song, X., Xu, T., Xia, C., Guo, Y., Weng, S., Gong, J., & Wang, F. (2025) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70217 · Cited by 4
“9,10 Therefore, the balance between these compartments is hypothesized to be a key determinant of cardiometabolic risk.”
Kim, N., Lee, M., Park, Y. K., & Lee, J. (2025) · Journal of the Korean Society of Food Science and Nutrition · doi:10.3746/jkfn.2025.54.10.805 · Cited by 1
Chen, Z., Zhang, Y., & Wang, L. (2025) · Digital Health · doi:10.1177/20552076251390574 · Cited by 2
“…mechanisms might explain this association: decreased muscle strength often re fl ects sarcopenia, which is associated with impaired glucose disposal 46 ; myokines secreted during muscle contraction improve insulin sensitivity 47 ; and muscle-adipose tissue crosstalk plays a critical role in…”
Imperatore, A., Mennitti, C., Fonzo, G. D., Amitrano, R., Gentile, A., Calvanese, M., IAFUSCO, F., Coppola, S., Digno, M., Borrelli, P., et al. (2025) · Genes · doi:10.3390/genes16111309 · Cited by 5
“IGF1 is also involved in glucose and lipid metabolism, playing a role in glucose homeostasis and promoting fatty acid β -oxidation during fasting, thereby reducing circulating lipid levels [220–223].”
Christiansen, S. F., Haug, K. B. F., Hussain, M., Hussein, A., Brusletto, B. S., Øvstebø, R., Witczak, O., & Aas, V. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1696916 · Cited by 3
The neuroprotective role of eucalyptol in a type-2 diabetes induced neuropathy rat model
Naseem, N., Hussain, M. S., Aziz, T., Imam, N., Hassan, M. N., Zehra, G. E. Z., & Siddiqui, W. A. (2025) · 3 Biotech · doi:10.1007/s13205-025-04612-y · Cited by 1
Ferreira, G. F., Carletti, T. M., Gama, L. T., Gonçalves, T. M. S. V., & Garcia, R. C. M. R. (2025) · Journal of Oral Rehabilitation · doi:10.1111/joor.70122 · Cited by 1
Mailloux‐Salinas, P., Jiménez‐Martínez, C., Arias‐Chávez, D. J., Gordillo-Bernal, A. A., Cid‐Gallegos, M. S., Alamilla‐Beltrán, L., & Bravo, G. (2025) · Molecules · doi:10.3390/molecules30244673 · Cited by 1
Gc inhibition preserves insulin sensitivity and reduces body weight without loss of muscle mass
Gill, R., & Kuo, T. (2025) · JCI Insight · doi:10.1172/jci.insight.195341 · Cited by 2
“%) in humans (33).”
Sex-specific associations of anthropometric markers with prediabetes in the general population
Naeem, M. T., Bibi, S., Bülow, R., Bahls, M., Schipf, S., Töpfer, P., Friedrich, N., Rathmann, W., Aghdassi, A. A., Nauck, M., et al. (2025) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2025.104515 · Cited by 2
TAS1R3 Regulates GTPase Signaling in Human Skeletal Muscle Cells for Glucose Uptake
Hoolachan, J. M., Balakrishnan, R., Merz, K. E., Thurmond, D. C., & Veluthakal, R. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010103 · Cited by 2
“In healthy individuals, skeletal muscle plays a central role in maintaining whole-body glucose homeostasis, accounting for ~70–90% of insulin-stimulated peripheral blood glucose uptake [6–8].”
Doğan, M., Doğan, B. D., & Basat, S. (2025) · Ahi Evran Medical Journal · doi:10.46332/aemj.1616577 · Cited by 1
Frigerio, F., Vitozzi, A., Piciocchi, C., Ricci, F., Marinis, M. G. D., Galfano, V., Lubrano, C., Mariani, S., Gangitano, E., Minnetti, M., et al. (2026) · International Journal of Obesity · doi:10.1038/s41366-025-01993-1 · Cited by 2
Shoyhet, H., Cohen, Y., Herman-Bachinsky, Y., Rosenhek‐Goldian, I., Kamyshinsky, R., Hornstein, E., & Levenberg, S. (2026) · ACS Nano Medicine · doi:10.1021/acsnanomed.5c00052 · Cited by 1
Diacylglycerol kinases: Molecular mechanism of cellular and physiological functions
Kimura, T., & Epand, R. M. (2026) · Progress in Lipid Research · doi:10.1016/j.plipres.2025.101373 · Cited by 2
Bidirectional association between sarcopenia and diabetic kidney disease: a prospective cohort study
Wu, L., Fubin, C., Lin, L., et al. (2026) · BMC Nephrology · doi:10.1186/s12882-025-04735-7 · Cited by 1
“Chronic energy surplus, ectopic lipid deposition, mitochondrial dysfunction, oxidative stress, and inflammatory signaling act in concert to blunt insulin action in skeletal muscle and liver [4].”
Silva, L. F. R., Silva, P. H. E., do Carmo, J. O., Garcia, B. C. C., Esteves, E. A., Dias‐Peixoto, M. F., Gripp, F., Chavez, O., Jr., Tricoli, V., Mang, Z. A., et al. (2026) · European Journal of Applied Physiology · doi:10.1007/s00421-026-06131-x · Cited by 1
“Because the skeletal muscle accounts for ~ 80% of the post-prandial glucose disposal (DeFronzo and Tripathy 2009), and exercise affects insulin sensitivity more specifically in this tissue (Richter et al. 1989), our results indicate that higher skeletal muscle glucose uptake, but not lower hepatic…”
Myokine SIRPα exacerbates kidney disease in diabetes
Wu, J., Russo, E., Verzola, D., Li, Q., Zhang, H., Krishnan, B., Sheikh‐Hamad, D., Hu, Z., Mitch, W. E., & Thomas, S. S. (2026) · JCI Insight · doi:10.1172/jci.insight.183392 · Cited by 1
Pescari, D., Mihuta, S., Bena, A., Pui, R., Paul, C., & Stoian, D. L. (2026) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2026.1792614 · Cited by 3
“Preservation of skeletal muscle mass within high-protein regimens may further contribute to improved peripheral glucose utilization and insulin sensitivity, particularly in individuals with obesity-related sarcopenia or long-standing insulin resistance (70).”
Luo, W., Xu, Y., Tao, Z., Sun, R., Li, X., Ji, Z., & Ma, G. (2026) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.70411 · Cited by 1
Pan, W., Liao, Y., Han, Y., Cao, C., & Hu, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1713333 · Cited by 2
“Skeletal muscle, the body ’ s largest insulin-responsive tissue, is central to glucose homeostasis (10).”
Du, J., Shu, X., Lin, T., Liao, H., Zhang, L., & Yue, J. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.03.095 · Cited by 5
The Association of Handgrip Strength in the Second Trimester with Gestational Hyperglycemia
Zu, P., Xu, J., Wang, P. H., Bian, J., Xu, M., Jiang, N., Luo, W., CHEN, X., & ZHU, P. (2026) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000003985 · Cited by 1
Metabolic Flux Adaptations During GLP-1 Receptor Agonist Therapy: Redox Implications
Lee, J., You, J. H., Park, H. J., Roh, J.-L., & Paek, S. H. (2026) · Current Obesity Reports · doi:10.1007/s13679-026-00709-4 · Cited by 3
“As skeletal muscle represents a major site of glucose disposal and systemic energy expenditure [89, 90 ], its preservation is central to durable metabolic adaptation.”
Azar, P. S., Akhlaghi, S., Shariat‐Madar, Z., & Mahdi, F. (2026) · Biomolecules · doi:10.3390/biom16040535 · Cited by 2
Exercise as a Metabolic Therapy for MASLD: Beyond Weight Loss Toward Sustainable Exercise Strategies
Roh, H., & Bae, J. Y. (2026) · Medicina · doi:10.3390/medicina62040784 · Cited by 1
Sonza, A., Faquin, A., Grugni, G., Bondesan, A., Caroli, D., Abbruzzese, L., & Sartorio, A. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15093248 · Cited by 1
“Skeletal muscle is the primary site of postprandial glucose disposal, and variations in muscle insulin sensitivity could influence the insulin required to regulate circulating glucose [30,31].”
Ziegelmayer, S., Häntze, H., Mertens, C. J., Busch, F., Lemke, T., Graf, M., Navab, N., Faghihroohi, S., Kather, J. N., Truhn, D., et al. (2026) · Radiology · doi:10.1148/radiol.251347 · Cited by 3
The emerging role of the Hippo signaling pathway in interorgan crosstalk
Song, G., Lee, C., & Jho, E. (2026) · FEBS Journal · doi:10.1111/febs.70587 · Cited by 1
Rethinking insulin resistance in aging: A reserve-oriented clinical framework
Boccardi, V., & Sinclair, A. J. (2026) · Ageing Research Reviews · doi:10.1016/j.arr.2026.103180 · Cited by 11
Save, S. N., Parveen, N., Sonis, G., Chavan, S., Chugh, J., & Sharma, S. (2026) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2026.153997 · Cited by 1
Chen, Z., Li, Y., Fang, Y., Huang, D., Esteban, M. Á., Chen, X., & Zhang, Y. (2026) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2026.110436 · Cited by 1
Ko, D., Low, J. J. Y., Lőw, P., Chua, D., Dan, Y. Y., Chen, V. L., Fallowfield, J. A., Kendall, T. J., Takahashi, H., Ng, C. H., et al. (2026) · npj gut and liver. · doi:10.1038/s44355-026-00061-3 · Cited by 5
Neto, W. H. J., Ramos, C. D. O., & de Souza, C. T. (2026) · Physiology & Behavior · doi:10.1016/j.physbeh.2026.115427 · Cited by 2
Mănescu, D. C., Plastoi, C. D., Pîrvan, A., Dîrnu, R., Floroiu, E. A., & Popescu, A. (2026) · Cells · doi:10.3390/cells15141236 · Cited by 6
Chrono-Exercise Medicine: Why Biological Timing Matters for Human Health
Hesketh, S. J. (2026) · Biomedicines · doi:10.3390/biomedicines14071601 · Cited by 4
“Beyond its fundamental role in locomotion, skeletal muscle is the largest insulin-sensitive organ in the body and a major regulator of systemic glucose disposal, energy expenditure, metabolic flexibility, and whole-body metabolic homeostasis [43].”
Dietary bioactive compounds targeting insulin resistance: mechanisms and preventive potential
Aiello, V., Lombardo, M., Aiello, G., Tripodi, G., Castelli, C., Matarese, G., Tamburro, M., Ripabelli, G., Baldelli, S., & Castelli, S. (2026) · Frontiers in Nutrition · doi:10.3389/fnut.2026.1918360 · Cited by 2
“In skeletal muscle, the primary site of insulin-stimulated glucose disposal, IR is mainly associated with impaired GLUT4 translocation to the plasma membrane, resulting in reduced glucose uptake (53).”
Belani, J. D. (2026) · Nutrients · doi:10.3390/nu18152578 · Cited by 1
“Insulin sensitivity, beta-cell function, hepatic glucose regulation [11,25], skeletal muscle glucose uptake [24], adiposity, circadian biology [29], sleep quality, physical activity [33], gut microbiome composition [26], medication use, and other physiological modifiers each influence how nutrients…”
Powell, R. O. (2014) · D-Scholarship@Pitt (University of Pittsburgh) · Cited by 1
Effect of bofutsushosan on insulin resistance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats
Kobayashi, R., Nagasaki, M., Saito, D., Zhuang, Q., Khookhor, O., Bajotto, G., Uno, T., & Sato, Y. (2012) · 和漢医薬学雑誌 · doi:10.11339/jtm.29.1 · Cited by 1
Bioinformatics of Metabolomics in Diabetes Mellitus Type 2
El-Lethy, A.-S. T., & Sliem, H. A. (2014) · Journal of Bioinformatics and Diabetes · doi:10.14302/issn.2374-9431.jbd-13-212 · Cited by 1
“Skeletal muscle is the primary site of insulin-mediated glucose disposal and contributes significantly to a decreased glucose uptake [7].”
BackgroundThe challenge of diabetes in Asia
James, W. P. T. (2017) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2017.77 · Cited by 1
An Integrative Omics Approach to Identify Sub-Network Biomarker in Type 2 Diabetes Mellitus
Al-Sabti, A., Zaibi, M. S., & Jassim, S. (2017) · UKSim European Symposium on Computer Modeling and Simulation (EMS) · doi:10.1109/ems.2017.20 · Cited by 2
The Endothelial Barrier Is not Rate-limiting to Insulin Action in the Myocardium of Male Mice
Sanwal, R., Khosraviani, N., Advani, S. L., Advani, A., & Lee, W. L. (2020) · Endocrinology · doi:10.1210/endocr/bqaa029 · Cited by 1
Assessing metabolic flexibility and mitochondrial bioenergetics
San-Millán, I. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00010-3 · Cited by 1
Abnormal mitochondrial metabolism in obesity and insulin resistance
de Mello, A. H., Ferreira, G. K., & Rezin, G. T. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00003-6 · Cited by 2
Islamic issues gain in global appeal
Dudley, N. (2004) · Euromoney eBooks · Cited by 1
Kusuma, R. J., Puspaningtyas, D. E., & Sari, P. M. (2021) · Nutrition & Food Science · doi:10.1108/nfs-01-2021-0017 · Cited by 1
Circadian Rhythms and Exercise Metabolism
Wolff, C. A., Hesketh, S. J., & Esser, K. A. (2022) · Physiology in health and disease · doi:10.1007/978-3-030-94305-9_16 · Cited by 1
Brown, E. E., Williams, A., Hakim, O., Wilton, M., Harrold, J. A., Hughes, D. M., Kemp, G. J., Wilding, J. P. H., Goff, L. M., & Cuthbertson, D. J. (2022) · JCSM Rapid Communications · doi:10.1002/rco2.70 · Cited by 2
Chronic Alcohol and Skeletal Muscle
Bourgeois, B. L., Levitt, D. E., Molina, P. E., & Simon, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-67928-6_49-1 · Cited by 2
Mahmud, S. Z., & Bashir, A. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4872 · Cited by 2
Mohapatra, S., Ramachandran, M., Behera, K. K., Priyadarsini, N., Nanda, P., & Devi, S. (2022) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2022.03.009 · Cited by 6
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.